Have a personal or library account? Click to login
Plasma levels of resistin predict cardiovascular events Cover

Plasma levels of resistin predict cardiovascular events

Revista Romana de Medicina de Laborator
Volume 22 (2014): Issue 1 (March 2014)
By: Luminița Vida-Simiti,  Irina Todor,  Mirela Stoia,  Claudia Gherman and  Cerasela Goidescu  
Open Access
|Mar 2014

References

  1. 1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-12. DOI: 10.1038/3505300010.1038/3505300011201732
    Search in Google Scholar
  2. 2. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87(6):2520-4. DOI: 10.1210/jcem.87.6.8528 DOI: 10.1210/ jc.87.6.252010.1210/jcem.87.6.852812050208
    Search in Google Scholar
  3. 3. Adeghate E. An update on the biology and physiology of resistin. Cell Mol Life Sci. 2004;61(19-20):2485-96. DOI: 10.1007/s00018-004-4083-210.1007/s00018-004-4083-215526156
    Search in Google Scholar
  4. 4. Stumvoll M, Haring H. Resistin and adiponectin--of mice and men. Obes Res. 2002;10(11):1197-9. DOI: 10.1038/oby.2002.16210.1038/oby.2002.16212429885
    Search in Google Scholar
  5. 5. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12(6):962-71. DOI: 10.1038/ oby.2004.11810.1038/oby.2004.11815229336
    Search in Google Scholar
  6. 6. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res. 2002;10(11):1095-103. DOI: 10.1038/ oby.2002.14910.1038/oby.2002.14912429872
    Search in Google Scholar
  7. 7. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334(4):1092-101. DOI: 10.1016/j.bbrc.2005.06.20210.1016/j.bbrc.2005.06.20216039994
    Search in Google Scholar
  8. 8. Barnes KM, Miner JL. Role of resistin in insulin sensitivity in rodents and humans. Curr Prot Peptide Sci. 2009;10(1):96-107. DOI: 10.2174/13892030978731523910.2174/13892030978731523919275676
    Search in Google Scholar
  9. 9. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309(2):286-90. DOI: 10.1016/j.bbrc.2003.07.00310.1016/j.bbrc.2003.07.00312951047
    Search in Google Scholar
  10. 10. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003;108(6):736-40. DOI: 10.1161/01. CIR.0000084503.91330.49
    Search in Google Scholar
  11. 11. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;255(4):439-47. DOI: 10.1111/j.1365-2796.2004.01306.x10.1111/j.1365-2796.2004.01306.x15049878
    Search in Google Scholar
  12. 12. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;11(8):997-1001. DOI: 10.1038/oby.2003.13710.1038/oby.2003.13712917505
    Search in Google Scholar
  13. 13. de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Perez Castrillon JL, et al. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res Clin Prac. 2009;84(2):174-8. DOI: 10.1016/j.diabres. 2009.01.017
    Search in Google Scholar
  14. 14. Pfutzner A, Langenfeld M, Kunt T, Lobig M, Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 2003;49(11-12):571-6.
    Search in Google Scholar
  15. 15. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci. 2005;9(3):161-5.
    Search in Google Scholar
  16. 16. Chen CC, Li TC, Li CI, Liu CS, Wang HJ, Lin CC. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism. 2005;54(4):471-5. DOI: 10.1016/j.metabol. 2004.10.015
    Search in Google Scholar
  17. 17. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res. 2005;13(10):1764-71. DOI: 10.1038/ oby.2005.21510.1038/oby.2005.21516286524
    Search in Google Scholar
  18. 18. Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Hear Cir Physiol. 2010;299(1):H193-201. DOI: 10.1152/ ajpheart.00431.200910.1152/ajpheart.00431.2009290413820435848
    Search in Google Scholar
  19. 19. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg. 2005;41(4):691-8. DOI: 10.1016/j. jvs.2004.12.046
    Search in Google Scholar
  20. 20. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, et al. The potential role of resistin in atherogenesis. Atherosclerosis. 2005;182(2):241-8. DOI: 10.1016/j.atherosclerosis.2005.02.01410.1016/j.atherosclerosis.2005.02.01416159596
    Search in Google Scholar
  21. 21. Xu W, Yu L, Zhou W, Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun. 2006;351(2):376-82. DOI: 10.1016/j.bbrc.2006.10.05110.1016/j.bbrc.2006.10.05117067553
    Search in Google Scholar
  22. 22. Rizkalla J, Melone M, Zhao A, Rashid S. The pathophysiological role of resistin in impaired lipoprotein metabolism in obesity. Circulation. 2009;120:S529.
    Search in Google Scholar
  23. 23. Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004;110(21):3335-40. DOI: 10.1161/01. CIR.0000147825.97879.E7
    Search in Google Scholar
  24. 24. Cohen G, Horl WH. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Semin Dial. 2009;22(4):373-7. DOI: 10.1111/j.1525-139X.2009.00583.x10.1111/j.1525-139X.2009.00583.x19708984
    Search in Google Scholar
  25. 25. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun. 2004;314(2):415-9. DOI: 10.1016/j.bbrc.2003.12.10410.1016/j.bbrc.2003.12.10414733921
    Search in Google Scholar
  26. 26. Sharma R, Kumar C, Gangwani S, Singh Sugga G, Rana AC. Resistin and cardiovascular disorder. Afr J of Pharm Pharmacol. 2011;5(1):5.10.1111/j.2042-7158.1986.tb14234.x
    Search in Google Scholar
  27. 27. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, et al. Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci. 2009;84(3-4):97-104. DOI: 10.1016/j.lfs.2008.11.00410.1016/j.lfs.2008.11.00419041881
    Search in Google Scholar
  28. 28. Li L, Han JL, Mao JM, Guo LJ, Gao W. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Med J. 2013;126(6):1058-62.
    Search in Google Scholar
  29. 29. Erer HB, Sayar N, Guvenc TS, Aksaray S, Yilmaz H, Altay S, et al. Prognostic value of serum resistin levels in patients with acute coronary syndrome. Kardiol Pol. 2014;72(2):181-6. DOI: 10.5603/KP.a2013.008610.5603/KP.a2013.008623633273
    Search in Google Scholar
  30. 30. Rosner B. Fundamentals of biostatistics. 5th ed. Pacific Grove, CA: Duxbury; 2000.
    Search in Google Scholar
  31. 31. Zhang MH, Na B, Schiller NB, Whooley MA. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and Soul study. J Card Fail. 2011;17(1):24-30. DOI: 10.1016/j.cardfail.2010.08.00710.1016/j.cardfail.2010.08.00721187261
    Search in Google Scholar
  32. 32. Anfossi G, Russo I, Doronzo G, Pomero A, Trovati M. Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators of inflammation. 2010;2010:174341. DOI: 10.1155/2010/17434110.1155/2010/174341290591120652043
    Search in Google Scholar
  33. 33. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J of Med. 1996;334(5):292-5. DOI: 10.1056/NEJM19960201334050310.1056/NEJM1996020133405038532024
    Search in Google Scholar
  34. 34. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes care. 2003;26(10):2883-9. DOI: 10.2337/diacare.26.10.288310.2337/diacare.26.10.288314514596
    Search in Google Scholar
  35. 35. Scholze A, Rattensperger D, Zidek W, Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring). 2007;15(6):1617-22. DOI: 10.1038/oby.2007.19110.1038/oby.2007.19117558000
    Search in Google Scholar
  36. 36. Sattar N, Wannamethee G, Sarwar N, Chernova J, Lawlor DA, Kelly A, et al. Leptin and coronary heart disease: prospective study and systematic review J Am Coll Cardiol. 2009;53(2):167-75. DOI: 10.1016/j. jacc.2008.09.035
    Search in Google Scholar
  37. 37. Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011;217(2):503-8. DOI: 10.1016/j. atherosclerosis.2010.10.047
    Search in Google Scholar
  38. 38. Owens CD, Kim JM, Hevelone ND, Hamdan A, Raffetto JD, Creager MA, et al. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg. 2010;51(5):1152-9. DOI: 10.1016/j.jvs.2009.12.05110.1016/j.jvs.2009.12.051286067320223619
    Search in Google Scholar
  39. 39. Osawa H, Doi Y, Makino H, Ninomiya T, Yonemoto K, Kawamura R, et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2009;8:60. DOI: 10.1186/1475-2840-8-6010.1186/1475-2840-8-60279044119922611
    Search in Google Scholar
  40. 40. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women’s Health Initiative. Stroke. 2011;42(7):1813-20. DOI: 10.1161/STROKEAHA. 110.607853
    Search in Google Scholar
  41. 41. Zhang MH, Na B, Schiller NB, Whooley MA. Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study. Atherosclerosis. 2010;213(2):604-10. DOI: 10.1016/j.atherosclerosis.2010.09.01510.1016/j.atherosclerosis.2010.09.01520951381
    Search in Google Scholar
  42. 42. Krecki R, Krzeminska-Pakula M, Peruga JZ, Szczesniak P, Lipiec P, Wierzbowska-Drabik K, et al. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up. Med Sci Monit. 2011;17(1):CR26-32. DOI: 10.12659/MSM.88132510.12659/MSM.881325352468121169907
    Search in Google Scholar
  43. 43. Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espinola-Klein C, Bickel C, et al. Resistin, acute coronary syndrome and prognosis results from the Athero- Gene study. Atherosclerosis. 2007;193(1):121-8. DOI: 10.1016/j.atherosclerosis.2006.05.03910.1016/j.atherosclerosis.2006.05.03916814296
    Search in Google Scholar
  44. 44. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis. 2009;20(1):33-9. DOI: 10.1097/ MCA.0b013e328318ecb010.1097/MCA.0b013e328318ecb018997620
    Search in Google Scholar
  45. 45. Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007;378(1-2):78-85. DOI: 10.1016/j.cca.2006.10.02310.1016/j.cca.2006.10.02317173885
    Search in Google Scholar
  46. 46. Pilz S, Weihrauch G, Seelhorst U, Wellnitz B, Winkelmann BR, Boehm BO, et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol. 2007;66(3):380-6. DOI: 10.1111/j.1365-2265.2007.02743.x10.1111/j.1365-2265.2007.02743.x17302872
    Search in Google Scholar
  47. 47. Hoefle G, Saely CH, Risch L, Koch L, Schmid F, Rein P, et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin Chim Acta. 2007;386(1-2):1-6. DOI: 10.1016/j.cca.2007.07.00110.1016/j.cca.2007.07.00117706624
    Search in Google Scholar
  48. 48. Luc G, Empana JP, Morange P, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond). 2010;34(1):118-26. DOI: 10.1038/ijo.2009.20410.1038/ijo.2009.20419823188
    Search in Google Scholar
  49. 49. Lim S, Koo BK, Cho SW, Kihara S, Funahashi T, Cho YM, et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis. 2008;196(1):398-404. DOI: 10.1016/j.atherosclerosis. 2006.11.017
    Search in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2014-0011 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 35 - 47
Published on: Mar 25, 2014
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
resistin,
leptin,
coronary artery disease,
peripheral arterial occlusive disease
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2014 Luminița Vida-Simiti, Irina Todor, Mirela Stoia, Claudia Gherman, Cerasela Goidescu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.

Previous articleVolume 22 (2014): Issue 1 (March 2014)Next article